Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-25-007997·Cadrenal Therapeutics, Inc.
Schedule 13D ownership disclosure
Cadrenal Therapeutics Inc
Common Stock, $0.001 par value per share · CUSIP: 127636207
Event date: 2025-01-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Quang X. PhamReported CIK 0001405290
Shares: 421,042.00 · Class: 23.6%
- The PVBQ Living TrustReported CIK 0001947432
Shares: 200,000.00 · Class: 11.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-007997
- Form type
- SCHEDULE 13D
- Filer
- Cadrenal Therapeutics, Inc.
- CIK
- CIK 1937993
- Filed
- Jan 29, 2025
- Reporting period
- Jan 23, 2025
- Description
- Schedule 13D beneficial ownership